These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 129042)

  • 1. Urinary excretion of 17-ketosteroids in patients suffering from mammary cancer.
    Görlich M; Heise E
    Arch Geschwulstforsch; 1975; 45(5):457-63. PubMed ID: 129042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of 17-ketosteriod excretion in mastopathia and premenopausal breast cancer.
    Hindy I; Prajda N; Tapolcsányi L; Sellei C; Eckhardt S
    Arch Geschwulstforsch; 1975; 45(5):453-6. PubMed ID: 129041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.
    Görlich M; Heise E; Pradja N; Hindy I
    Arch Geschwulstforsch; 1975; 45(7):648-57. PubMed ID: 132149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary 17-ketosteroid fractions in young patients with breast cancer.
    Chiricuţă I; Frenkel Z; Muteanu S
    Endocrinologie; 1978; 16(2):135-7. PubMed ID: 150018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of principal 17-ketosteroid fractions in urine of breast cancer patients with or without malignant evolutive push.
    Kiricuta I; Frenkel Z; Munteanu S
    Arch Geschwulstforsch; 1978; 48(6):565-8. PubMed ID: 153123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary excretion of 11-deoxy-17-ketosteroids during the normal menstrual cycle (author's transl)].
    Bolufer P; Rodríguez A; Micó JM
    Rev Esp Fisiol; 1975 Jun; 31(2):115-8. PubMed ID: 125907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic results of a study of bilateral adrenalectomy for advanced breast cancer. Urinary steroids and related data in 148 patients.
    Sarfaty G; Pitt P; Tallis M
    Med J Aust; 1973 Nov; 2(19):877-81. PubMed ID: 4128906
    [No Abstract]   [Full Text] [Related]  

  • 8. Benign and malignant breast disease in South Wales: a study of urinary steroids.
    Cameron EH; Griffiths K; Gleave E; Stewart HJ; Forrest AP; Campbell H
    Br Med J; 1970 Dec; 4(5738):768-71. PubMed ID: 4250592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
    Wetchler BB; McCarrick J; Allerhand J; Dreiling DA
    Mt Sinai J Med; 1974; 41(5):682-6. PubMed ID: 4278335
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary free cortisol, cortisone, cortisol sulfate, cortisone sulfate and 17-ketosteroids in breast cancer.
    Stancáková A; Klimesová Z
    Neoplasma; 1979; 26(2):205-13. PubMed ID: 157439
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal influences in breast cancer.
    Forrest AP
    Proc R Soc Med; 1971 May; 64(5):509-16. PubMed ID: 4252687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Excretion of 17-ketosteroid fractions in leukemia patients following prednisolone therapy].
    Szatmári E; Fehér T
    Z Gesamte Inn Med; 1971 Aug; 26(15):495-7. PubMed ID: 4258506
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary 17-ketosteroid excretion of women with advanced breast cancer.
    Kumaoka S; Sakauchi N; Abe O; Kusama M; Takatani O
    J Clin Endocrinol Metab; 1968 May; 28(5):667-72. PubMed ID: 4231599
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary excretion of neutral 17-ketosteroids and their fractions in men with coronary heart disease.
    Sznajderman M
    Pol Med J; 1968; 7(6):1298-305. PubMed ID: 4238092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary excretion of neutral 17-ketosteroids, androsterone and etiocholanolone in healthy women and women with early and advanced breast cancer].
    Bacigalupo G; Lingk H
    Arch Geschwulstforsch; 1968; 32(1):95-107. PubMed ID: 5678251
    [No Abstract]   [Full Text] [Related]  

  • 16. [The mechanism of action of hydrocortisone administered by lumbar puncture in breast cancer].
    Bordiushkov IuN; Mindlin SS; Verkhovtseva AI
    Vopr Onkol; 1973; 19(9):19-23. PubMed ID: 4274750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal patterns in breast cancers].
    Kiricuta I; Frenkel Z; Munteanu S
    Arch Geschwulstforsch; 1974; 44(3):260-6. PubMed ID: 4460955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparing metabolic studies following infusion of dehydroepiandrosterone sulfate and dehydroepiandrosterone phosphate].
    Schubert K; Frankenberg G; Bacigalupo G
    Endokrinologie; 1965 Dec; 49(1):12-7. PubMed ID: 4225496
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and hormonal aspects in breast cancer with special reference to malignant evolutive push.
    Kiricuta I; Frenkel Z; Munteanu S
    Arch Geschwulstforsch; 1975; 45(5):464-72. PubMed ID: 1212065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of urinary 17-ketosteroid fractions in breast cancer--correlation with the effect of adrenalectomy in progressive breast cancer].
    Sakauchi N; Abe O; Kusama M; Takatani O; Kato N
    Saishin Igaku; 1968 Feb; 24(2):463-70. PubMed ID: 4239286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.